Racial disparities in urologic health care

Journal of the National Medical Association

Volumn 102, Issue 2, 2010, Pages 108-118

  Klein, John B ^a   Nguyen, Carvell T ^a   Saffore, Lateef ^a   Modlin III, Charles ^a   Modlin Jr , Charles S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cultural competency; Health care; Health disparities; Race ethnicity; Urology

Indexed keywords

FATTY ACID; PROSTATE SPECIFIC ANTIGEN; VITAMIN D;

AFRICAN AMERICAN; BLADDER CANCER; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER THERAPY; CHROMOSOME ABERRATION; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CULTURAL COMPETENCE; DIET; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ERECTILE DYSFUNCTION; FEEDING BEHAVIOR; HEALTH CARE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEREDITY; HISPANIC; HUMAN; INCIDENCE; INTERPERSONAL COMMUNICATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; MINORITY GROUP; ONSET AGE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RACISM; REVIEW; SOYBEAN; TESTIS CANCER; TREATMENT OUTCOME; TREATMENT PLANNING; UROLOGICAL CARE;

EID: 77649173579     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0027-9684(15)30498-3     Document Type: Review

References (89)

1. Elo IT. New African American life tables from 1935-1990. Demography. 2001;38(1):97-114.
2. Modlin CS. Culture, race, and disparities in health care. Cleve Clin J Med. 2003;70(4):283,287-288.
3. Centers for Disease Control and Prevention life expectancy data, http://www.cdc.gov/nchs/fastats/lifexpec.htm.
4. Smedley B, Stith A, Nelson A, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press: 2002.
5. National Center on Minority Health and Health Disparities, National Institutes of Health, US Department of Health and Human Services, http://www.ncmhd.nih.gov.
6. Dressler WW, Oths KS, Gravlee CC. Race and ethnicity in public health research: models to explain health disparities. Ann Rev Anthro. 2005;34:231-252.
7. Centers for Disease Control and Prevention, Racial & Ethnic Populations. Office of Minority Health, Reports & Publications, Black or African American Populations. http://www.cdc.gov/omh/Populations/BAA/BAA.htm.
8. US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2010. http://odphp.osophs.dhhs.gov.
9. Office of Minority Health, Resource Center Staff, Data and Statistics. African American Profile, http://www.omhrc.gov/templates/browse.aspx?lvl= 2&lvllD=51.
10. American Cancer Society. Cancer statistics for 2001-2006. http://www.cancer.org/docroot/STT/content/STT-1x-Cancer-Facts-Figures-2009.asp? from=fast
11. Fine MJ, Ibrahim SA, Thomas SB. The role of race and genetics in health disparities research. Am J Public Health. 2005;95(12):2125-2128.
12. Miller BA, Kolonel LN, Bernstein L et al. Racial/Ethnic Patterns of Cancer in the United States 1988-1992. Bethesda, MD: National Cancer Institute; 1996. NIH Publication 96-4104.
13. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the Nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95:17:1276-1299.
14. Evans M. Healthcare's minority report. Sullivan Commission, IOM try to make patient, hospital staff makeup more reflective of the nation's everchanging population. Mod Healthc. 2004;34(39):6-7,14.
15. Betancourt JR, Maina AW. The Institute of Medicine reports "Unequal Treatment": implications for academic health centers. Mt Sinai J Med. 2004;71(5):314.
16. Juckett G. Cross-Cultural medicine. Am Fam Physician. 2005;72(11):2267-2274.
17. Misra-Hebert A. Physician cultural competence: Cross-cultural communication improves care. Cleve Clin J Med. 2003;70:289-303.
18. Ndubuisi SC, Kofie VY, Andoh JY, et al.. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology. 1995;46(1):71-77.
19. Polednak AP, Flannery JT. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer. 1992:70(8):2152-2158.
20. Oakley-Girvan I, Kolonel LN, Gallagher RP, et al. Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients. Am J Public Health. 2003;93(10):1753-1759.
21. Weinrich SP. Prostate cancer screening in high-risk men: African American hereditary prostate cancer study network. Cancer. 2006;106(4):796-803.
22. Stone A, Ratnasinghe LD, Emerson GL, et al. CYP3A43 Pro (340) Ala polymorphism and prostate cancer risk in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2005;14(5):1257-1261.
23. Kittles RA, Boffoe-Bonnie A, Moses T, et al. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history. J Med Genet. 2006;43(6):507-11.
24. Powell I, Sakr W, Weiss L, et al. Prostate cancer is biologically more aggressive among African Americans than Caucasian men under age 70: hypothesis supported by autopsy and SEER data. Program and abstracts from the American Urological Association 95th Annual Meeting; April 29 to May 4, 2000.
25. Makridakis NM, Ross RK, Pike MC, et al. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet. 1999;354(9183):975-978.
26. Ahaghotu C, Baffoe-Bonnie A, Kittles R, et al. Clinical characteristics of African-American men with hereditary prostate cancer the AAHPC Study. Prostate Cancer Prostatic Dis. 2004;7(2):165-169.
27. Visakorpi T. The molecular genetics of prostate cancer. Urology. 2003;62.(5 suppl 1):3-10.
28. Kwabi-Addo B, Giri D, Schmidt K, et al. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci USA. 2001;98:11563-11568.
29. Umbos R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule e-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 1992;52:5104-5109.
30. Palmberg C, Koivisto P, Kakkola L, et al. Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer. J Urol 2000;164:1992-1995.
31. Visakorpi T. Molecular genetics of prostate cancer. Ann Chir Gynaecol. 1999;88(1):11-16.
32. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence, and mortality. Part I: international comparisons. Br J Urol. 2002;90:162-173.
33. Delongchamps NB, Singh A, Haas GP. Epidemiology of prostate cancer in Africa: another step in the understanding of the disease?. Curr Probl Cancer. 2007;31(3):226-236.
34. Shimizu H, Ross RK, Bernstein L, et al. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer. 1991;63(6):963-966.
35. McCarty MF. Mortality from western cancers rose dramatically among African-Americans during the 20th century: are dietary animal products to blame? Med Hypotheses. 2001;57(2):169-174.
36. McCormick DL, Johnson WD, Bosland MC, et al. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor. Nutr Cancer. 2007;57(2):184-193.
37. Oakley-Girvan I, Feldman D, Eccleshall TR, et al. Risk of early-onset prostate cancer in relation to germ line polymorphisms of the Vitamin D receptor. Cancer Epidemiol Biomarkers Prev. 2004;13(8):1325-1330.
38. Freedland SJ, Isaacs WB. Explaining racial differences in prostate cancer in the United States: sociology or biology? Prostate. 2005;62(3):243-252.
39. Ross LE, Berkowitz Z, Ekwueme DU. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008;17(3):636-644.
40. Boyd MD, Weinrich SP, Weinrich M, et al. Obstacles to prostate cancer screening in African-American men. J Natl Black Nurses Assoc. 2001;12(2):1-5.
41. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin. 2003;53(1):5-26.
42. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
43. Hoffman RM, Gilliland FD, Eley JW, et al. Racial and ethnic differences in advanced-stage prostate cancer the prostate cancer outcomes study. J Natl Cancer Inst. 2001;93(5):388-395.
44. Kyle C, Ewing T, Wu XC, et al. Statewide analysis of serum prostate specific antigen levels in Louisiana men without prostate cancer. J La State Med Soc. 2004;156(6):319-323.
45. Vijayakumar S, Winter K, Sause W, et al. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12. Int J Radiat Oncol Biol Phys. 1998;40(1):17-25.
46. Polednak AP. Prostate cancer treatment in black and white men: the need to consider both stage at diagnosis and socioeconomic status. J Natl Med Assoc. 1998;90(2):101-104.
47. Grossfeld GD, Latini DM, Downs T, et al. Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy? J Urol. 2002;168(6):2510-2515.
48. Hoffman RM, Harlan LC, Klabunde CN, et al. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med. 2003;18(10):845-853.
49. Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci. 2006;11:1388-1413.
50. Demers RY, Tiwari A, Wei J, et al. Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality. Cancer. 2001;92(9):2309-2317.
51. Merrill RM, Lyon JL. Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology. 2000;55(5) 730-735.
52. Fowler JE Jr, Terrell F. Survival in blacks and whites after treatment for localized prostate cancer. J Urol. 1996;156(1):133-136.
53. Tewari A, Horninger W, Badani KK, et al. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer. Br J Urol Int. 2005;96(1):29-33.
54. Bozeman C, Williams BJ, Whatley T, et al. Clinical and biopsy specimen features in black and white men with clinically localized prostate cancer. South Med J. 2000;93(4):400-402.
55. US Renal Data System, USRDS 2001-2005 Annual Data Report, http://www.usrds.org/adr.htm.
56. United Network Organ for Sharing data March 19, 2005, database Organ Procurement and Transplantation Network (OPTN). http://www.unos.org/whatWeDo/ research.asp.
57. Callender CO, Miles PV, Hall MB, et al. Blacks, whites, and kidney transplantation: A disparity! But why and why won't it go away? Transplant Rev. 2002;16(3):163-176.
58. Hertz RP, Unger AN, Cornell JA, et al. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165(18):2098-2104.
59. Fuster V, O'Rourke R, Walsh R, eds. Hurst's The Heart. New York, NY: McGraw-Hill; 2007.
60. Epstein AM, Ayanian JZ, Keogh JH, et al. Racial disparities in access to renal transplantation - clinically appropriate or due to underuse or overuse? N Engl J Med. 200;343(21):1537-1544.
61. Klassen AC, Hall AG, Saksvig B, et al. Relationship between patients' perceptions of disadvantage and discrimination and listing for kidney transplantation. Am J Public Health. 2002;92(5):811-817.
62. Young CJ, Gaston RS. Renal transplantation in black Americans. N Engl J Med. 2000;343(21):1545-1552.
63. Navaneethan SD, Singh S. A systematic review of barriers in access to renal transplantation among African Americans in the United States. Clin Transplant. 2006;20(6):769-775.
64. Modlin CS, Novick AC. Renal transplantation. In: Weiss RM, George NJR, O'Reilly PH, eds. Comprehensive Urology. London, England: Mosby; 2001;275-294.
65. United Network for Organ Sharing Web site. http://www.unos.org/.
66. Rozon-Solomon M, Burrows L. 'Tis better to receive than to give: the relative failure of the African American community to provide organs for transplantation. Mt Sinai J Med. 1999;66(4):273-276.
67. Modlin CS, Goldfarb DA. The use of expanded criteria cadaver and live donor kidneys for transplantation. Urol Clin North Am. 2001;28(4):687-707.
68. Modlin CS, Flechner SM, Goormastic M, et al. Should obese patients lose weight before receiving a kidney transplant? Transplantation. 1997;64(4):599-604.
69. Podder H, Podbielski J, Hussein I, et al. Sirolimus improves the two-year outcome of renal allografts in African-American patients. Transpl Int. 2001;14:135-142.
70. Shibagaki Y, Shetty A. Anemia is common after kidney transplantation, especially among African Americans. Nephrol Dial Transplant. 2004;19(9):2368-2373.
71. National Kidney NODE is an initiative of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health & Human Services.
72. Garg PP, Diener-West M, Powe NR. Income-based disparities in outcomes for patients with chronic kidney disease. Semin Nephrol. 2001;21(4):377-385.
73. UNOS Data Request, http://www.unos.org/data/request-main.asp.
74. Hicks LS, Cleary PD, Epstein AM, et al. Differences in health-related quality of life and treatment preferences among black and white patients with end-stage renal disease. Qual Life Res. 2004;13(6):1129-1137.
75. Furth SL, Garg PP, Neu AM, et al. Racial differences in access to the kidney transplant waiting list for children and adolescents with end-stage renal disease. Pediatrics. 2000;106(4):756-761.
76. Underwood W, Dunn RL, Williams C, et al. Gender and geographic influence on the racial disparity in bladder cancer mortality in the US. J Am Coll Surg. 2006:202(2):284-290.
77. Taub DA, Hollenbeck BK, Cooper KL, et al. Racial disparities in resource utilization for cystectomy. Urology. 2006:67(2):288-293.
78. Gajendran VK, Nguyen M, Ellison LM. Testicular cancer patterns in African-American men. Urology. 2005;66(3):602-605.
79. McGlynn KA, Devesa SS, Graubard BI, et al. Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol. 2005;23(24):5757-5761.
80. Saigal CS, Wessells H, Pace J, et al. Urologic Diseases in America Project. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166(2):207-212.
81. Barqawi A, O'Donnell C, Kumar R, et al. Correlation between LUTS (AUA-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: data from the Prostate Cancer Awareness Week (PCAW). Int J Impot Res. 2005;17(4):370-374.
82. Black-White disparities in health care. Council on ethical and judicial affairs. JAMA. 1990;263(17):2344-2346.
83. U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion. Healthy People 2010 initiative, http://odphp.osophs.dhhs. gov, http://www.healthypeople.gov.
84. Zaramo CEB, Modlin CS. "2006 Minority Men's Health Fair Profile," Health Section: May 25, 2006, Volume 90, Number 24. Pages 79. Cleveland Clinic Minority Men's Health Center.
85. Zaramo, CEB, Modlin, CS. "Delivering World-Class Care in Their Own Backyard", Minority Health MENtor a Publication of the Minority Men's Health Center Glickman Urological Institute; Spring 2006, Volume 3.
86. Zaramo CEB, Modlin CS. "Health Literacy Curriculums". A Call and Post Publication Minority Men's Health of the Cleveland Clinic, March 14th, 2006, Volume 89, Number 25. Pages 70.
87. National Center on Minority Health and Health Disparities 2003-2005. http://ncmhd.nih.gov. Dr. Nahi, Christina: Press Release Disparity in Nation's Schools: Race and Poverty Linked to Educational Inequality and Higher Dropout Rates, Cambridge, MA - January 13, 2005 - Today, The Civil Rights Project at Harvard University: Vol. 4, Issue 3, Winter 2005.
88. Calman NS, Hauser D, Forte G et al. New York State physicians: characteristics and distribution in health professional shortage areas. J Urban Health. 2007;84(2):307-309.
89. Komaromy M, Grumbach K, Drake M, et al. The role of black and Hispanic physicians in providing health care for underserved populations. N Engl J Med. 1996;334(20):1305-1310.